The tramadol option

European Journal of Pain

Volumn 4, Issue SUPPL. A, 2000, Pages 15-21

  Desmeules, J A ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CODEINE; IMIPRAMINE; MORPHINE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE DERIVATIVE; TRAMADOL;

ANALGESIA; CONFERENCE PAPER; DISEASE SEVERITY; DOSE RESPONSE; DRUG ABUSE; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG INDICATION; DRUG MECHANISM; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; HIGH RISK PATIENT; HUMAN; NAUSEA; NEUROPATHY; PAIN; PRESCRIPTION; PRIORITY JOURNAL; RHEUMATIC DISEASE; VERTIGO;

EID: 0034507334     PISSN: 10903801     EISSN: None     Source Type: Journal    
DOI: 10.1053/eujp.1999.0163     Document Type: Conference Paper

References (27)

1. Changes in brain monoamine metabolism during withdrawal chronic oral self-administration of morphine and in response to morphine challenge in the withdrawn state
2. The clinical use of tramadol hydrochloride
3. A postmarketing surveillance program to monitor Ultram® (tramadol hydrochloride) abuse in the United States
4. General tolerability and adverse event profile of tramadol hydrochloride
5. Bioactivation of the narcotic drug codeine in human liver is mediated by the polymorphic monooxygenase catalyzing debrisoquine 4-hydroxylation (cytochrome P-450 dbl/bufI)
6. Impact of environmental and genetic factors on codeine analgesia
7. Contribution of monoaminergic modulation to the analgesic tramadol
8. Role of the CYP2D6 in pharmacokinetics and analgesic effects of tramadol enantiomers
9. Treatment of pain due to postherpetic neuralgia with tramadol. Results of an open, parallel pilot study versus clomipramine with or without levomepromazine
10. Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy
11. Analgesic-antipyretic and antiinflammatory agents and drugs employed in the treatment of gout
12. The risk of seizures associated with tramadol
13. Pharmacology and clinical experience with tramadol in osteoarthritis
14. Tramadol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in acute and chronic pain states
15. Analgesics, anti-inflammatory drugs and antipyretics
16. The hypoalgesic effect of tramadol in relation to CYP2D6
17. A novel approach to the pharmacology of analgesics
18. Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an 'atypical' opioid analgesic
19. Slowing the initial titration rate of tramadol improves tolerability
20. Non-NSAID pharmacologic treatment options for the management of chronic pain
21. Tramadol allows reduction of naproxen dose among patients with naproxen-responsive osteoarthritis pain
22. Tramadol relieves pain and allodynia in polyneuropathy: A randomised, double-blind, controlled trial
23. Tramadol. A review of its use in perioperative pain
24. Comparison of the analgesic efficacy and tolerability of tramadol 100 mg sustained-release tablets and tramadol 50 mg capsules for the treatment of chronic low back pain
25. Tramadol: Pain relief by an opioid without depression of respiration
26. The analgesic tramadol has minimal effect on gastrointestinal motor function